1. Home
  2. Disease & Disorders
  3. Pittsburgh, PA
  4. Community Liver Alliance

Community Liver Alliance

Community Liver Alliance is ranked #17 of 19 disease & disorders organizations in Pittsburgh, PA, with an America's Best Score of 64 out of 100, based on its 2025 Form 990.

  • Pittsburgh, PA
  • Tax-exempt since 2013
  • EIN: 46-1909171
communityliveralliance.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate
64OF 100 #17 of 19 in Pittsburgh ranked disease & disorders organizations How this score is calculated

Organization summary

Community Liver Alliance is a 501(c)(3) organization, classified under Disease & Disorders (NTEE G40). Contributions are tax-deductible.

100 W Station Square Dr, Pittsburgh, PA 15219-1175

Among the 22 scored disease & disorders organizations in Pittsburgh, Community Liver Alliance holds 11 months of operating reserves (peer median 14.8 months), runs a typical yearly deficit of 5.1% (peers: surplus of 3.6%), and has grown spending 7.8% a year (peers: grown spending 9.6% a year).

In fiscal year 2025 it reported $689,189 in revenue and $798,018 in expenses, with contributions making up 98.2% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2025 Form 990

Supporting the community through liver disease awareness, prevention, education, and research.

Largest programs · fiscal year 2025

  • Education - the following education events were held during 2025.liver cancer conference - at course completion, attendees should be able to understand and have more knowledge of the molecular classification of hepatocellular cancer (hcc) and the multidisciplinary approach to management of hcc competency, define the mechanisms that lead to the development of hcc, discuss the available evidence-bas… Read more

    Education - the following education events were held during 2025.liver cancer conference - at course completion, attendees should be able to understand and have more knowledge of the molecular classification of hepatocellular cancer (hcc) and the multidisciplinary approach to management of hcc competency, define the mechanisms that lead to the development of hcc, discuss the available evidence-based data on promising treatment options for advanced hcc and the advances in research and development.nash update - at course completion, attendees should have an increased knowledge base regarding therapy for nonalcoholic steatohepatitis (nash) and nonalcoholic fatty liver disease (nafld) related to medication and endoscopic treatments, an increased knowledge base regarding management for nash and nafld related to nutritional and weight therapies, and an increased knowledge base regarding options of extra-hepatic manifestations of nash.nash update for patients & caregivers - the cla "patient and caregiver nash update" educational program is a provider lead update for patients and caregivers. The program format includes up to date information about current treatments for fatty liver, nafld, and nash, new developments and clinical trials, transplantation, nutrition, Medicaid and Medicare update, resources, and a question & answer session. A post-program evaluation is conducted to determine other areas of education needed. It is also a chance for patients to network.post aasld (American association for the study of liver disease) - the goal of this program is to help clinicians and other service providers understand the local and regional picture of viral hepatitis, management of hepatocellular carcinoma, autoimmune and fatty liver disease in the U.S. Population, and to offer strategies forprevention and control of chronic hepatitis and corresponding chronic liver disease.hcv training - the goal of this program is to help clinicians and other service providers understand the local and regional picture of hepatitis c, hcv/HIV coinfection, diagnosis, treatment, management and education and to offer strategies for prevention and control of chronic hepatitis and corresponding chronic liver disease.primary biliary cholangitis (pbc) caregiver education - the cla "pbc update" educational program is a providerlead update for patients and caregivers, and providers are also invited to attend. The program format includes upto date information about pbc current treatments, new developments and clinical trials, transplantation, nutrition, Medicaid and Medicare update, resources, and a question and answer session. A post-program evaluation isconducted to determine other areas of education needed. It is also a chance for patients to network and learnabout the cla lead pbc support group.

    $335,533 spent · 71.6% of program spending
  • Viral hepatitis elimination - activities performed by the organization communicating the purpose and services of the organization to all potential sources of research and development. $31,548 spent · 6.7% of program spending
  • Advocacy - activities performed by the organization communicating the purpose and services of the organization to all potential sources of research and development. $100,408 spent · 21.4% of program spending
  • Mash challenge $500 spent · 0.1% of program spending
  • Liver hero program - the cla liver hero fund was established to raise funds to support three important initiatives: (1) Local research each year $25,000 is invested through the liver research funding program. The purpose of the program is to provide funding for a local liver research project; (2) Patient assistance fund often times patients have hardships balancing life expenses during treatment a… Read more

    Liver hero program - the cla liver hero fund was established to raise funds to support three important initiatives: (1) Local research each year $25,000 is invested through the liver research funding program. The purpose of the program is to provide funding for a local liver research project; (2) Patient assistance fund often times patients have hardships balancing life expenses during treatment and transplant. The cla patient assistance program provides a maximum grant of $250 per patient, per year towards approved expenses; and (3) Children's hospital of Pittsburgh camp chihopi youth transplant camp camp chihopi allows youth transplant patients to experience time away from the hospital and the daily difficulty of being a patient. Each August children gather at camp emma kaufman in West Virginia to enjoy 4 days of activities and friendships. The donations of the live hero fund are 100% directed towards these initiatives.

    $600 spent · 0.1% of program spending

Where each dollar went · fiscal year 2025

Of every dollar it spent, 59¢ went to programs, 20¢ to management and 21¢ to fundraising.

  • Programs $468,589
  • Management $162,491
  • Fundraising $166,938

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

America's Best Score

Free assessmentMethodology
Score64 / 100
Rank in Pittsburgh#17 of 19
DesignationRanked

Score breakdown

MeasureThis organizationPoints
Operating reserves11.0 mo; 10.9 mo in cash7.6 / 25
Financial balance (median margin)−5.1%9.5 / 20
Transparency4 full 990s, latest TY202520 / 20
Program growth+7.8% / yr11.4 / 15
Track record13 years5.2 / 10
Debt load2.9% of assets10 / 10
Total63.7 → 64
Spending on programs
Not scored; America's Best needs 65%+
59%Below

Compared with Pittsburgh peers

MeasureThis organizationPeer median
Operating reserves11.0 mo14.8 mo
Typical margin−5.1%+3.6%
Spending growth+7.8% / yr+9.6% / yr
Debt load2.9%4.2%

Peers: the 22 Pittsburgh disease & disorders organizations with a score, ranked or below the bar.

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$689,189Fiscal year 20252022: $518,38020222023: $631,54520232024: $628,73920242025: $689,1892025
Expenses$798,018Fiscal year 20252022: $637,18020222023: $610,03320232024: $574,08720242025: $798,0182025
Total assets$752,713Fiscal year 20252022: $840,64720222023: $840,87520232024: $891,73320242025: $752,7132025
Total liabilities$21,668Fiscal year 20252022: $80,90220222023: $55,65320232024: $51,85920242025: $21,6682025
Fiscal year ending December 2025
Revenue$689,189
Expenses$798,018
Net income−$108,829
Net assets$731,045

Notable sources of revenue

Percent of total revenue
Contributions$676,947
Program services$2,350
Investment income$19,512
Other (net)−$9,620

Assets / debt

Total assets$752,713
Total liabilities$21,668
Net assets$731,045

Compensation

Not in our extract for this year.

Fiscal year ending December 2024
Revenue$628,739
Expenses$574,087
Net income$54,652
Net assets$839,874

Notable sources of revenue

Percent of total revenue
Contributions$590,722
Program services$256
Investment income$21,938
Other (net)$15,823

Assets / debt

Total assets$891,733
Total liabilities$51,859
Net assets$839,874

Compensation

Not in our extract for this year.

Fiscal year ending December 2023
Revenue$631,545
Expenses$610,033
Net income$21,512
Net assets$785,222

Notable sources of revenue

Percent of total revenue
Contributions$647,523
Program services$0
Investment income$1,561
Other (net)−$17,539

Assets / debt

Total assets$840,875
Total liabilities$55,653
Net assets$785,222

Compensation

Not in our extract for this year.

Fiscal year ending December 2022
Revenue$518,380
Expenses$637,180
Net income−$118,800
Net assets$759,745

Notable sources of revenue

Percent of total revenue
Contributions$536,709
Program services$0
Investment income$4,213
Other (net)−$22,542

Assets / debt

Total assets$840,647
Total liabilities$80,902
Net assets$759,745

Compensation

Officers and key employees$125,000
Share of expenses19.6%

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?